Multimedia Aid for Genetic Testing in Gynecologic Oncology

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUNC Lineberger Comprehensive Cancer Center

About this trial

This pilot study aims to estimate rates of genetic testing in patients with ovarian and endometrial cancer before and after the implementation of educational videos about genetic testing. Subjects will be asked to view one of three videos relevant to their cancer diagnosis and genetic testing, and have the option to complete a brief satisfaction survey. A chart review to evaluate rates of genetic testing ordered and referrals placed to Genetics before and after the implementation of the videos will be conducted.

Up to 15-20% of ovarian cancer and 3-5% of endometrial cancer is due to inherited genetic mutation. Given this association, the National Comprehensive Cancer Network (NCCN) recommends genetic counseling and testing for all individuals with a diagnosis of ovarian cancer and endometrial cancer. Some challenges to obtaining genetic counseling and testing include missed identification and referral of eligible patients by providers, lack of provider knowledge, and busy clinic visits limiting time for informed consent and maintaining patient autonomy for genetic testing. Although heterogeneous, the literature supports multimedia use in cancer genetics. However, there is a paucity of data in the field of gynecologic oncology for the role of integrating a multimedia approach to genetic counseling.

Eligibility criteria

Qualifiers

Reviewed informed consent to participate in the study.

Subject is willing and able to comply with study procedures based on the judgment of the investigator.

Age ≥ 18 years at the time of consent.

Diagnosis of ovarian cancer or endometrial cancer

Disqualifiers

Previously completed genetic testing

Did not receive initial cancer-directed treatment at study site

Trial design

Treatments tested in this trial

  • Educational videos
  • Survey

Treatment groups

30 Participants
are divided into 1 treatment group